natgillin/translations-raw huggingface dataset:
GNA applies a different business plan methodology compared to the one applied in the ING report mentioned in footnote 98.
GNA uporablja metodologijo poslovnega načrta, ki je drugačna od metodologije iz poročila družbe ING, navedenega v opombi 98.
In GNA’s methodology, a cost of capital indicator was not required.
Po metodologiji podjetja GNA se kazalnik stroška kapitala ne zahteva.
However, in its analysis, the Commission also used the cost of capital figures to benchmark the IRR rate of GNA’s business plan.
Komisija pa je v svoji analizi uporabila tudi podatke o stroških kapitala, da je lahko primerjala notranjo stopnjo donosnosti poslovnega načrta podjetja GNA.
See also recital 134 and following.
Glej tudi uvodno izjavo 134 in naslednje.
See recital 41.
Glej odstavek uvodno izjavo 41.
The authorities provided the Commission with loan agreements on […] and it is stated that the interest charged is equal to […] %.
Organi so Komisiji predložili posojilne pogodbe o […] in navedeno je, da zaračunane obresti znašajo […] %.
Namely the ‘three-layer model’, where the passive and the active layers are operated and managed separately, with an open and non-discriminatory access offered to all retail operators, see also Figure 1.
To je „triplastni model“, v katerem se pasivna in aktivna plast upravljata in vodita ločeno, z odprtim in nediskriminacijskim dostopom, ponujenim vsem maloprodajnim operaterjem; glej tudi Prikaz 1.
Small risky investments can also be explained by real option theory, according to which risky investments can entail a two-stage process.
Majhne tvegane naložbe je mogoče razložiti tudi s teorijo realne opcije, po kateri lahko tvegane naložbe vključujejo postopek v dveh fazah.
In the first stage, only a small investment is made (i.e. the company is purchasing an option).
V prvi fazi se izvede le majhna naložba (tj. podjetje kupi opcijo).
Some time later, when more information is known, the company can make a larger investment (i.e. exercising this option) or abandon its plans, thereby limiting its losses to the initial small-scale investment (i.e. to the costs of the option).
Čez nekaj časa, ko je znanih več informacij, lahko podjetje uresniči večjo naložbo (tj. izvedba navedene opcije) ali opusti svoje načrte ter s tem omeji svoje izgube na začetno majhno naložbo (tj. na stroške opcije).
By shouldering higher risk and uncertainty in the first stage (with small commitment), companies can reduce the risks of subsequent (larger) investments.
S prevzemanjem večjega tveganja in negotovosti v prvi fazi (z majhno stopnjo zavezanosti) lahko podjetja zmanjšajo tveganja nadaljnjih (večjih) naložb.
The Commission considers that the IRR ratio appears to be the most appropriate parameter for an analysis of the business plan.
Komisija meni, da je stopnja notranje donosnosti projekta videti najprimernejši parameter za analizo poslovnega načrta.
The IRR is used to make decisions on long-term investments and to compare different investment projects.
Notranja donosnost projekta se uporablja pri odločanju o dolgoročnih naložbah in primerjavi različnih naložbenih projektov.
Communication from the Commission to the Council and the European Parliament. Common Actions for Growth and Employment: The Community Lisbon Programme, COM(2005) 330 of 20 July 2005.
Sporočilo Komisije Svetu in Evropskemu parlamentu – Skupni ukrepi za rast in zaposlovanje: Lizbonski program Skupnosti, COM(2005) 330 konč., 20.7.2005.
In the current case, the municipality of Amsterdam invests EUR 6 million in the partnership GNA. Since a municipality is to be considered as an emanation of the State, this is to be considered as an investment with State resources within the meaning of Article 87(1) of the EC Treaty [60].
V obravnavani zadevi mestna občina Amsterdam vlaga v podjetje GNA 6 milijonov EUR. Ker za mestno občino velja, da izvira iz države, mora tudi naložba šteti za naložbo, izvedeno iz državnih sredstev v smislu člena 87(1) Pogodbe ES [60].
authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean A2704-12 (ACS-GMØØ5-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
o odobritvi dajanja na trg proizvodov, ki vsebujejo gensko spremenjeno sojo A2704-12 (ACS-GMØØ5-3), so iz nje sestavljeni ali proizvedeni, v skladu z Uredbo (ES) št. 1829/2003 Evropskega parlamenta in Sveta
(notified under document number C(2008) 4735)
(notificirano pod dokumentarno številko C(2008) 4735)
On 1 July 2005, Bayer CropScience AG submitted to the competent authority of the Netherlands an application, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003, for the placing on the market of foods, food ingredients, and feed containing, consisting of, or produced from A2704-12 soybean (‘the application’).
Družba Bayer CropScience AG je 1. julija 2005 v skladu s členoma 5 in 17 Uredbe (ES) št. 1829/2003 pristojnemu organu Nizozemske predložila vlogo za dajanje na trg živil, živilskih sestavin in krme, ki vsebujejo sojo A2704-12, so iz nje sestavljeni ali proizvedeni („vloga“).
The application also covers the placing on the market of other products containing or consisting of A2704-12 soybean for the same uses as any other soybean with the exception of cultivation.
Vloga zajema tudi dajanje na trg drugih proizvodov, ki vsebujejo sojo A2704-12 ali so iz nje sestavljeni, za enako uporabo kot katero koli drugo vrsto soje, razen za gojenje.
Therefore, in accordance with the provisions of Articles 5(5) and 17(5) of Regulation (EC) No 1829/2003, it includes the data and information required by Annexes III and IV to Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC [2] and information and conclusions about the risk assessment carried out in accordance with the principles set out in Annex II to Directive 2001/18/EC.
Zato vključuje vloga v skladu z določbami člena 5(5) in člena 17(5) Uredbe (ES) št. 1829/2003 podatke in informacije iz prilog III in IV k Direktivi 2001/18/ES Evropskega parlamenta in Sveta z dne 12. marca 2001 o namernem sproščanju gensko spremenjenih organizmov v okolje in razveljavitvi Direktive Sveta 90/220/EGS [2] ter informacije in sklepne ugotovitve o oceni tveganja, ki je bila izvedena v skladu z načeli iz Priloge II k Direktivi 2001/18/ES.
On 10 August 2007, the European Food Safety Authority (EFSA) gave a favourable opinion in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003 and concluded that it is unlikely that the placing on the market of the products containing, consisting of, or produced from A2704-12 soybean as described in the application (‘the products’) will have any adverse effects on human or animal health or the environment in the context of their intended uses [3].
Evropska agencija za varnost hrane („EFSA“) je 10. avgusta 2007 dala ugodno mnenje v skladu s členoma 6 in 18 Uredbe (ES) št. 1829/2003 in sklenila, da ni verjetno, da bo dajanje na trg proizvodov, ki vsebujejo sojo A2704-12, so iz nje sestavljeni ali proizvedeni, kakor je opisano v vlogi („proizvodi“), imelo škodljive učinke na zdravje ljudi, živali ali okolje v okviru predvidene uporabe [3].
In its opinion, EFSA considered all the specific questions and concerns raised by the Member States in the context of the consultation of the national competent authorities as provided for by Articles 6(4) and 18(4) of that Regulation.
EFSA je v svojem mnenju preučila vsa specifična vprašanja in pomisleke držav članic v okviru posvetovanja z nacionalnimi pristojnimi organi, določenega v členu 6(4) in členu 18(4) navedene uredbe.
In particular, EFSA concluded that after considering all the data available in the application on the molecular characterisation, compositional analysis and agronomic performance, A2704-12 soybean is equivalent to its non-genetically modified counterpart and, as a consequence, that no further animal safety studies with the whole food/feed (e.g. a 90-day toxicity study in rats) are needed.
EFSA je po proučitvi vseh razpoložljivih podatkov pri uporabi molekularne karakterizacije, analizi strukture in agronomske učinkovitosti zlasti navedla, da je soja A2704-12 enakovredna svoji gensko nespremenjeni različici, zato nadaljnje študije na živalih o varnosti s celotnimi živili/krmo niso potrebne (npr. 90-dnevne študije toksičnosti na podganah).
In its opinion, EFSA also concluded that the environmental monitoring plan, consisting of a general surveillance plan, submitted by the applicant is in line with the intended use of the products.
EFSA je v svojem mnenju tudi navedla, da je načrt za spremljanje okolja, sestavljen iz splošnega načrta za nadzor, ki ga je predložil vlagatelj, v skladu z nameravano uporabo proizvodov.
Taking into account those considerations, authorisation should be granted for the products.
Ob upoštevanju teh vidikov je treba te proizvode odobriti.
A unique identifier should be assigned to each genetically modified organism (GMO) as provided for in Commission Regulation (EC) No 65/2004 of 14 January 2004 establishing a system for the development and assignment of unique identifiers for genetically modified organisms [4].
Vsakemu gensko spremenjenemu organizmu je treba dodeliti posebni identifikator, kakor določa Uredba Komisije (ES) št. 65/2004 z dne 14. januarja 2004 o vzpostavitvi sistema za razvijanje in dodeljevanje posebnih identifikatorjev za gensko spremenjene organizme [4].
On the basis of the EFSA opinion, no specific labelling requirements other than those provided for in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003, appear to be necessary for the foods, food ingredients and feed containing, consisting of, or produced from A2704-12 soybean.
V skladu z mnenjem EFSA za živila, živilske sestavine in krmo, ki vsebujejo sojo A2704-12, so iz nje sestavljeni ali proizvedeni, niso potrebne nobene posebne zahteve za označevanje, razen tistih, določenih v členih 13(1) in 25(2) Uredbe (ES) št. 1829/2003.
However, in order to ensure the use of the products within the limits of the authorisation provided by this Decision, the labelling of feed containing or consisting of the GMO and other products than food and feed containing or consisting of the GMO for which authorisation is requested should be complemented by a clear indication that the products in question must not be used for cultivation.
Vendar mora biti za zagotovitev uporabe proizvodov v okviru odobritve iz te odločbe iz oznak krme, ki vsebuje gensko spremenjene organizme ali je sestavljena iz njih, ter drugih proizvodov, ki niso živila in krma ter vsebujejo ali so sestavljeni iz gensko spremenjenih organizmov, za katere je predložena vloga za odobritev, jasno razvidno, da se zadevni proizvodi ne smejo uporabljati za gojenje.
Similarly, the EFSA opinion does not justify the imposition of specific conditions or restrictions for the placing on the market and/or specific conditions or restrictions for the use and handling, including post-market monitoring requirements, or of specific conditions for the protection of particular ecosystems/environment and/or geographical areas, as provided for in point (e) of Articles 6(5) and 18(5) of Regulation (EC) No 1829/2003.
Na podlagi mnenja EFSA tudi ni utemeljena uvedba posebnih pogojev ali omejitev za dajanje na trg in/ali posebnih pogojev ali omejitev za uporabo in ravnanje, vključno z zahtevami za spremljanje po začetku trženja, ali posebnih pogojev za zaščito posebnih ekosistemov/okolja in/ali geografskih območij, kakor je določeno v točki (e) člena 6(5) in člena 18(5) Uredbe (ES) št. 1829/2003.
Article 4(6) of Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms and amending Directive 2001/18/EC [5], lays down labelling requirements for products consisting or containing GMOs.
Člen 4(6) Uredbe (ES) št. 1830/2003 Evropskega parlamenta in Sveta z dne 22. septembra 2003 o sledljivosti in označevanju gensko spremenjenih organizmov ter sledljivosti živil in krme, proizvedenih iz gensko spremenjenih organizmov, ter o spremembi Direktive 2001/18/ES [5] določa zahteve za označevanje proizvodov, ki so sestavljeni iz gensko spremenjenih organizmov ali jih vsebujejo.
This decision is to be notified through the Biosafety Clearing House to the Parties to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity, pursuant to Articles 9(1) and 15(2)(c), of Regulation (EC) No 1946/2003 of the European Parliament and of the Council of 15 July 2003 on transboundary movements of genetically modified organisms [6].
O tej odločbi je treba prek posredovalnice informacij o biološki varnosti obvestiti pogodbenice Kartagenskega protokola o biološki varnosti h Konvenciji o biološki raznovrstnosti v skladu s členom 9(1) in členom 15(2)(c) Uredbe (ES) št. 1946/2003 Evropskega parlamenta in Sveta z dne 15. julija 2003 o čezmejnem gibanju gensko spremenjenih organizmov [6].
The Standing Committee on the Food Chain and Animal Health has not delivered an opinion within the time limit laid down by its Chairman; the Commission has therefore submitted a proposal to the Council on 28 April 2008 in accordance with Article 5 of the Council Decision 1999/468/EC [7], the Council being required to act within three months.
Stalni odbor za prehranjevalno verigo in zdravje živali ni dal mnenja v roku, ki ga je določil njegov predsednik; zato je Komisija 28. aprila 2008 Svetu predložila predlog v skladu s členom 5 Sklepa Sveta 1999/468/ES [7], Svet pa bi moral ukrepati v treh mesecih.
However, the Council has not acted within the required time limit; a Decision should now be adopted by the Commission,
Vendar se Svet ni odzval v zahtevanem roku; zato mora Komisija sprejeti odločbo –
Genetically modified organism and unique identifier
Gensko spremenjen organizem in posebni identifikator
Genetically modified soybean (Glycine max) A2704-12, as specified in point (b) of the Annex to this Decision, is assigned the unique identifier ACS-GMØØ5-3, as provided for in Regulation (EC) No 65/2004.
Gensko spremenjeni soji (Glycine max) A2704-12, opredeljeni v točki (b) Priloge k tej odločbi, se dodeli posebni identifikator ACS-GMØØ5-3, kakor je določeno v Uredbi (ES) št. 65/2004.
The following products are authorised for the purposes of Articles 4(2) and 16(2) of Regulation (EC) No 1829/2003 in accordance with the conditions set out in this Decision:
Za namene členov 4(2) in 16(2) Uredbe (ES) št. 1829/2003 se v skladu s pogoji iz te odločbe odobrijo naslednji proizvodi:
foods and food ingredients containing, consisting of, or produced from ACS-GMØØ5-3 soybean;
živila in živilske sestavine, ki vsebujejo sojo ACS-GMØØ5-3, so iz nje sestavljeni ali proizvedeni;
feed containing, consisting of, or produced from ACS-GMØØ5-3 soybean;
krma, ki vsebuje sojo ACS-GMØØ5-3, je iz nje sestavljena ali proizvedena;
products other than food and feed containing or consisting of ACS-GMØØ5-3 soybean for the same uses as any other soybean with the exception of cultivation.
proizvodi, ki niso živila in krma ter vsebujejo sojo ACS-GMØØ5-3 ali so iz nje sestavljeni, za enako uporabo kot katera koli druga soja, razen za gojenje.
For the purposes of the labelling requirements laid down in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003 and in Article 4(6) of Regulation (EC) No 1830/2003, the ‘name of the organism’ shall be ‘soybean’.
Za namene zahtev za označevanje iz člena 13(1) in člena 25(2) Uredbe (ES) št. 1829/2003 ter člena 4(6) Uredbe (ES) št. 1830/2003 je „ime organizma“„soja“.
The words ‘not for cultivation’ shall appear on the label of and in documents accompanying products containing or consisting of ACS-GMØØ5-3 soybean referred to in Article 2(b) and (c).
Besede „ni za gojenje“ se navedejo na oznakah proizvodov in v dokumentih, priloženih k proizvodom, ki vsebujejo sojo ACS-GMØØ5-3 ali so iz nje sestavljeni, navedenih v členu 2(b) in (c).
The authorisation holder shall submit to the Commission annual reports on the implementation and the results of the activities set out in the monitoring activities.
Imetnik odobritve Komisiji predloži letna poročila o izvajanju in rezultatih dejavnosti, določenih v ukrepih za spremljanje.
The authorisation holder shall be Bayer CropScience AG.
Imetnik odobritve je Bayer Cropscience AG.
This Decision is addressed to Bayer CropScience AG, Alfred-Nobel-Straße 50, D-40789 Monheim am Rhein, Germany
Ta odločba je naslovljena na Bayer CropScience AG, Alfred-Nobel-Strasse 50, D-40789 Monheim am Rhein, Nemčija
OJ L 184, 17.7.1999, p 23.
UL L 184, 17.7.1999, str. 23.
Applicant and authorisation holder:
Vlagatelj in imetnik odobritve:
Name Bayer CropScience AG.
Ime Bayer CropScience AG
Address Alfred-Nobel-Strasse 50, D-40789 Monheim am Rhein, Germany .
Naslov Alfred-Nobel-Strasse 50, D-40789 Monheim am Rhein, Nemčija
Foods and food ingredients containing, consisting of, or produced from ACS-GMØØ5-3 soybean.
živila in živilske sestavine, ki vsebujejo sojo ACS-GMØØ5-3, so iz nje sestavljeni ali proizvedeni;
Feed containing, consisting of, or produced from ACS-GMØØ5-3 soybean.
krma, ki vsebuje sojo ACS-GMØØ5-3, je iz nje sestavljena ali proizvedena;
Products other than food and feed containing or consisting of ACS-GMØØ5-3 soybean for the same uses as any other soybean with the exception of cultivation.
proizvodi, ki niso živila in krma ter vsebujejo sojo ACS-GMØØ5-3 ali so iz nje sestavljeni, za enako uporabo kot katera koli druga soja, razen za gojenje.
The genetically modified ACS-GMØØ5-3 soybean, as described in the application, expresses the PAT protein which confers tolerance to the glufosinate-ammonium herbicide.
Gensko spremenjena soja ACS-GMØØ5-3, kakor je opisana v vlogi, izloča protein PAT, ki povzroča odpornost na herbicid glufosinat-amonij.
For the purposes of the specific labelling requirements laid down in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003, and in Article 4(6) of Regulation (EC) No 1830/2003, the ‘name of the organism’ shall be ‘soybean’.
Za namene posebnih zahtev za označevanje iz člena 13(1) in člena 25(2) Uredbe (ES) št. 1829/2003 ter člena 4(6) Uredbe (ES) št. 1830/2003 je „ime organizma“„soja“.
The words ‘not for cultivation’ shall appear on the label of and in documents accompanying products containing or consisting of ACS-GMØØ5-3 soybean referred to in Article 2(b) and (c) of this Decision.
Besede „ni za gojenje“ se navedejo na oznakah proizvodov in v dokumentih, priloženih k proizvodom, ki vsebujejo sojo ACS-GMØØ5-3 ali so iz nje sestavljeni, navedenih v členu 2(b) in (c) te odločbe.
event specific real-time PCR-based method for the quantification of ACS-GMØØ5-3 soybean,
Kvantitativna, za pojav specifična metoda, ki temelji na polimerazni verižni reakciji (PCR) v realnem času, za sojo ACS-GMØØ5-3.
validated on seeds by the Community reference laboratory established under Regulation (EC) No 1829/2003, published at http://gmo-crl.jrc.it/statusofdoss.htm
Na podlagi semen potrdi referenčni laboratorij Skupnosti, ustanovljen z Uredbo (ES) št. 1829/2003, objava na spletni strani http://gmo-crl.jrc.it/statusofdoss.htm
reference material: AOCS 0707-A, AOCS 0707-B and AOCS 0707-C accessible via the American Oil Chemists Society at http://www.aocs.org/tech/crm/bayer_soy.cfm
Referenčni material: AOCS 0707-A, AOCS 0707-B in AOCS 0707-C na voljo pri American Oil Chemists Society na strani http://www.aocs.org/tech/crm/bayer_soy.cfm
Unique identifier:
Posebni identifikator:
Information required under Annex II to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity:
Informacije, zahtevane v Prilogi II h Kartagenskemu protokolu o biološki varnosti h Konvenciji o biološki raznovrstnosti:
Biosafety Clearing House, Record ID: see [to be completed when notified].
Posredovalnica informacij o biološki varnosti, oznaka zapisa: glej [izpolniti po uradnem obvestilu]
Conditions or restrictions on the placing on the market, use or handling of the products:
Pogoji ali omejitve pri dajanju proizvodov na trg, njihovi uporabi ali ravnanju z njimi:
Not required.
Se ne zahteva.
Monitoring plan:
Načrt spremljanja
Monitoring plan for environmental effects conforming with Annex VII to Directive 2001/18/EC.
Načrt spremljanja učinkov na okolje v skladu s Prilogo VII Direktive 2001/18/ES.
Post-market monitoring requirements for the use of the food for human consumption:
Zahteve za spremljanje po začetku trženja za uporabo živil za prehrano ljudi
Note: Links to relevant documents may need to be modified over time.
Opomba: Povezave do ustreznih dokumentov bo morda treba sčasoma spremeniti.
Political and Security Committee Decision CHAD/4/2008
Sklep Političnega in varnostnega odbora CHAD/4/2008
of 2 September 2008
z dne 2. septembra 2008
amending Political and Security Committee Decision CHAD/1/2008 on the acceptance of third States’ contributions to the European Union military operation in the Republic of Chad and in the Central African Republic and Political and Security Committee Decision CHAD/2/2008 on the setting up of the Committee of Contributors for the European Union military operation in the Republic of Chad and in the Central African Republic
o spremembi Sklepa Političnega in varnostnega odbora CHAD/1/2008 o sprejetju prispevka tretjih držav k vojaški operaciji Evropske unije v Republiki Čad in Srednjeafriški republiki in Sklepa Političnega in varnostnega odbora CHAD/2/2008 o vzpostavitvi odbora sodelujočih držav za vojaško operacijo Evropske unije v Republiki Čad in Srednjeafriški republiki
(2008/731/CFSP)
(2008/731/SZVP)
Having regard to Political and Security Committee Decision CHAD/1/2008 of 13 February 2008 on the acceptance of third States’ contributions to the European Union military operation in Chad and in the Central African Republic [2], and to Political and Security Committee Decision CHAD/2/2008 of 18 March 2008 on the setting-up of the Committee of Contributors for the European Union military operation in the Republic of Chad and in the Central African Republic [3],
ob upoštevanju Sklepa Političnega in varnostnega odbora CHAD/1/2008 z dne 13. februarja 2008 o sprejetju prispevka tretjih držav k vojaški operaciji Evropske unije v Republiki Čad in Srednjeafriški republiki [2] in Sklepa Političnega in varnostnega odbora CHAD/2/2008 z dne 18. marca 2008 o vzpostavitvi odbora sodelujočih držav za vojaško operacijo Evropske unije v Republiki Čad in Srednjeafriški republiki [3],
Following the recommendations on the contribution from the Republic of Croatia by the EU Operation Commander and the European Union Military Committee, the contribution from the Republic of Croatia should be accepted.
Na podlagi priporočil poveljnika operacije EU in Vojaškega odbora Evropske unije glede prispevka Republike Hrvaške bi bilo treba prispevek Republike Hrvaške sprejeti.
Article 1 of Political and Security Committee Decision CHAD/1/2008 shall be replaced by the following:
Člen 1 Sklepa Političnega in varnostnega odbora CHAD/1/2008 se nadomesti z naslednjim:
Following the Force Generation Conferences and further consultations, the contributions from the Republic of Albania, the Russian Federation and the Republic of Croatia shall be accepted for the EU military operation in the Republic of Chad and in the Central African Republic.’
Na podlagi konferenc o oblikovanju sil in nadaljnjih posvetovanj se sprejmejo prispevki Republike Albanije, Ruske federacije in Republike Hrvaške za vojaško operacijo EU v Republiki Čad in Srednjeafriški republiki.“
The Annex to Political and Security Committee Decision CHAD/2/2008 shall be replaced by the following:
Priloga k Sklepu Političnega in varnostnega odbora CHAD/2/2008 se nadomesti z naslednjim:
Done at Brussels, 2 September 2008.
V Bruslju, 2. septembra 2008
Council Decision 2008/732/CFSP
Sklep Sveta 2008/732/SZVP
Having regard to Common Position 2004/293/CFSP [1], and in particular Article 2 thereof, in conjunction with Article 23(2) of the Treaty on European Union,
ob upoštevanju Skupnega stališča 2004/293/SZVP [1] in zlasti člena 2 Skupnega stališča v povezavi s členom 23(2) Pogodbe o Evropski uniji,